1. Structural activation of pro-inflammatory human cytokine IL-23 by cognate IL-23 receptor enables recruitment of the shared receptor IL-12Rβ1;Bloch;Immunity,2018
2. Bloch, Y., Felix, J., Merceron, R., Provost, M., Symakani, R.A., Backer, R.D., Lambert, E., Savvides, S.N., 2023. Structures of complete extracellular receptor assemblies mediated by IL-12 and IL-23. bioRxiv, 2023.2003.2013.532366.
3. Interleukins in cancer: from biology to therapy;Briukhovetska;Nat. Rev. Cancer,2021
4. Case, D.A., Babin, V., Berryman, J.T., Betz, R.M., Cai, Q., Cerutti, D.S., Cheatham, T.E. III, Darden, T.A., Duke, R.E., Gohlke, H., Goetz, A.W., Gusarov, S., Homeyer, N., Janowski, P., Kaus, J., Kolossváry, I., Kovalenko, A., Lee, T.S., LeGrand, S., Lucko, T., Luo, R., Madej, B., Merz, K.M., Paesani, F., Roe, D.R., Roitberg, A., Sagui, C., Salomon-Ferrer, R., Seabra, G., Simmerling, C.L., Smith, W., Swails, J., Walker, R.C., Wang, J., Wolf, R.M., Wu, X., Kollmann, P.A., 2014. AMBER 14.
5. Novel strategies exploiting interleukin-12 in cancer immunotherapy;Cirella;Pharmacol. Ther.,2022